SICKLE CELL ANEMIA TESTING AND SCREENING MARKET Size and trends

Sickle Cell Anemia Testing and Screening Market, By Testing Method (Hemoglobin Electrophoresis, High-Performance Liquid Chromatography (HPLC), Point-of-Care Tests, Genetic Testing, and Others), By Age Group (Newborn Screening, Ages 1 to 25, and Ages 26 and Above), By Sector (Government Labs, Private Labs, Corporate Labs, and PPP), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI7523
Pages :130
Formats :
Excel and PDF
Industry : Pharmaceutical

Sickle Cell Anemia Testing And Screening Market Size and Trends

The global sickle cell anemia testing and screening market is estimated to be valued at USD 522.0 Mn in 2025 and is expected to reach USD 1,169.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2025 to 2032.

Sickle Cell Anemia Testing and Screening Market Key Factors

To learn more about this report, Request sample copy

The increasing prevalence of sickle cell anemia globally primarily drives the market growth. Various players in the market like PerkinElmer, Inc. are focusing on new product launches, especially Point-of-Care (POC) testing kits for sickle cell screening. This is expected to boost the market growth over the forecast period.